Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -213,090 | -175,149 | -114,397 | -167,211 | -157,803 |
| Depreciation Amortization | 45,387 | 45,738 | 14,023 | 11,011 | 8,544 |
| Income taxes - deferred | -193,605 | N/A | -115 | N/A | N/A |
| Accounts receivable | -27,633 | -17,292 | -17,529 | -3,593 | -3,557 |
| Accounts payable and accrued liabilities | 3,469 | 33,076 | 30,537 | -2,598 | 661 |
| Other Working Capital | -53,556 | -911 | -7,678 | 1,763 | -1,295 |
| Other Operating Activity | 327,373 | 45,598 | 23,435 | 30,562 | 19,433 |
| Operating Cash Flow | $-111,655 | $-68,940 | $-71,724 | $-130,066 | $-134,017 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,023,087 | -613,720 | -85,585 | 3,332 | -42,771 |
| PPE Investments | -172,654 | -150,093 | -48,480 | -14,851 | -20,084 |
| Net Acquisitions | -973,861 | -17,908 | -2,980 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -20,690 | 0 | -1,900 |
| Other Investing Activity | -1,000 | -578 | -23,760 | 0 | -1,900 |
| Investing Cash Flow | $-124,428 | $-782,299 | $-160,805 | $-11,519 | $-64,755 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 729,477 | 896,430 | N/A | N/A | 5,062 |
| Debt Repayment | -493,356 | N/A | N/A | -166 | -404 |
| Common Stock Issued | 17,183 | 11,531 | 261,332 | 149,752 | 177,107 |
| Other Financing Activity | -123 | 26,181 | -376 | 0 | 0 |
| Financing Cash Flow | $253,181 | $934,142 | $260,956 | $149,586 | $181,765 |
| Exchange Rate Effect | N/A | 36 | 143 | -215 | 11 |
| Beginning Cash Position | 160,430 | 77,491 | 48,921 | 41,135 | 58,131 |
| End Cash Position | 177,528 | 160,430 | 77,491 | 48,921 | 41,135 |
| Net Cash Flow | $17,098 | $82,939 | $28,570 | $7,786 | $-16,996 |
| Free Cash Flow | |||||
| Operating Cash Flow | -111,655 | -68,940 | -71,724 | -130,066 | -134,017 |
| Capital Expenditure | -172,654 | -150,093 | -48,480 | -14,851 | -20,084 |
| Free Cash Flow | -284,309 | -219,033 | -120,204 | -144,917 | -154,101 |